TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34350897

Group type: EXPERIMENTAL
Intervention: Early steered stimulation
Number of subjects: 13

Group type: COMPARATOR
Intervention: Delayed steered stimulation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Early steered stimulation and Delayed steered stimulation
Number of subjects: 13
Study: 34952736

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 15 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (10 ml saline)
Number of subjects: 30
Study: 34487722

Group type: EXPERIMENTAL
Intervention: Start oral anticoagulation (101 participants)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Avoid oral anticoagulation (102 participants)
Number of subjects: 203
Study: 616666876

Group type: EXPERIMENTAL
Intervention: hANP
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: ARC (hANP + ARB)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 286
Study: 35618748

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 33152688

Group type: EXPERIMENTAL
Intervention: Standing desk
Number of subjects: 36

Group type: COMPARATOR
Intervention: Seated desk
Number of subjects: 36
Study: 35505437

Group type: EXPERIMENTAL
Intervention: Measurement-based care (MBC)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: MBC
Number of subjects: 900

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 900
Study: 32964986

Group type: EXPERIMENTAL
Intervention: VASPIN treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VASPIN treatment in HK-2 cells
Number of subjects: 0
Study: 36113532

Group type: EXPERIMENTAL
Intervention: One dose of 2-valent vaccine (Cervarix)
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: One dose of 9-valent vaccine (Gardasil 9)
Number of subjects: 930
Study: 34310978

Group type: EXPERIMENTAL
Intervention: TVB-2640 25 mg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: TVB-2640 50 mg
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 32691850

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 76
Study: 34595801

Group type: EXPERIMENTAL
Intervention: Slow deep breathing (SDB) intervention, 20-minute video 5 times weekly for 4 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (normal activities)
Number of subjects: 14
Study: 33891721

Group type: EXPERIMENTAL
Intervention: IPTp-DHP
Number of subjects: 956

Group type: COMPARATOR
Intervention: IPTp-SP
Number of subjects: 956
Study: 32858264

Group type: EXPERIMENTAL
Intervention: E-learning video curriculum for outpatient pediatric endocrinology rotation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no e-learning video curriculum)
Number of subjects: 41
Study: 36171046

Group type: EXPERIMENTAL
Intervention: OnTrack intervention (12 weeks using the OnTrack system comprising arm tracking and coaching support for self-management)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: OnTrack intervention
Number of subjects: 12
Study: 34856687

Group type: EXPERIMENTAL
Intervention: Rishulin
Number of subjects: 563

Group type: COMPARATOR
Intervention: NovoRapid
Number of subjects: 563
Study: 35686334

Group type: EXPERIMENTAL
Intervention: AFP ratio <37.9 (high-risk group)
Number of subjects: 368

Group type: COMPARATOR
Intervention: AFP ratio >37.9 (low-risk group)
Number of subjects: 368
Study: 32720602

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day) + Ezetimibe (10 mg/day)
Number of subjects: 18144

Group type: COMPARATOR
Intervention: Simvastatin (40 mg/day) monotherapy
Number of subjects: 18144
Study: 32202256

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir combination therapy for 14 days
Number of subjects: 0
Study: 36031718

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg ethanol
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1 g/kg ethanol
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 33455765

Group type: EXPERIMENTAL
Intervention: Propylene glycol (PG) at 15.0 μL/g of dry matter (TRT)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (0 μL/g of dry matter, CON)
Number of subjects: 4
Study: 32337700

Group type: EXPERIMENTAL
Intervention: Low-dose nalmefene (N1 group, n=40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-dose nalmefene (N2 group, n=40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (physiologic saline, n=40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (physiologic saline)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low-dose nalmefene (N1 group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-dose nalmefene (N2 group)
Number of subjects: 120
Study: 35090675

Group type: EXPERIMENTAL
Intervention: eRegistry with clinical decision support
Number of subjects: 6367

Group type: COMPARATOR
Intervention: Paper-based documentation
Number of subjects: 6367
Study: 33910605

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) application during ACL surgery
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group without PRP application
Number of subjects: 34
Study: 32876468

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mock transcutaneous electrical nerve stimulation and sham acupuncture (n=25)
Number of subjects: 50
Study: 36041396

Group type: EXPERIMENTAL
Intervention: 0.45 mg/kg selenium-enriched yeast (SeY)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study: 33905907

Group type: COMPARATOR
Intervention: Standard pterional approach (PtA)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS) - transeyelid approach (TelA)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS) - nanopterional approach (NPtA)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 111
Study: 32438659

Group type: EXPERIMENTAL
Intervention: Gradually salt-reduced bread
Number of subjects: 309

Group type: COMPARATOR
Intervention: Gradually salt-reduced bread and dietary counselling
Number of subjects: 309

Group type: COMPARATOR
Intervention: Standard bread (control)
Number of subjects: 309
Study: 35861901

Group type: EXPERIMENTAL
Intervention: PRINT group (modified PVI line according to esophageal fingerprint)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CONTROL group (standard PVI with operator blinded to the fingerprint)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PRINT group
Number of subjects: 60

Group type: COMPARATOR
Intervention: CONTROL group
Number of subjects: 60
Study: 34867233

Group type: EXPERIMENTAL
Intervention: Insight Questions Inventory (IQI) and Visual Support Strategies (IQI VSS)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Standard therapy for CP
Number of subjects: 191
Study: 32906138

Group type: EXPERIMENTAL
Intervention: iStent implantation and cataract surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Phacoemulsification alone (control group)
Number of subjects: 80
Study: 35637515

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program for 2.5 hours weekly for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care management
Number of subjects: 40
Study: 33243368

Group type: EXPERIMENTAL
Intervention: e-coachER intervention
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (exercise referral schemes alone)
Number of subjects: 450
Study: 33434080

Group type: EXPERIMENTAL
Intervention: Fortified low-fat yogurt (1500 IU nano encapsulated vitamin D3 per 150 g/d)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Fortified low-fat milk (1500 IU nano encapsulated vitamin D3 per 200 g/d)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Fortified low-fat milk
Number of subjects: 306

Group type: COMPARATOR
Intervention: Fortified low-fat yogurt and fortified low-fat milk
Number of subjects: 306
Study: 32423935

Group type: EXPERIMENTAL
Intervention: Salt Control H (innovative prototype equipment to monitor and control use of salt when cooking)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 260
Study: 35788492

Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg once daily
Number of subjects: 420

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 420
Study: 32412597

Group type: EXPERIMENTAL
Intervention: Whole roasted almonds
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control snacks (mini-muffins)
Number of subjects: 107
Study: 34245981

Group type: EXPERIMENTAL
Intervention: Prior eating disorder (ED) diagnosis
Number of subjects: 159

Group type: COMPARATOR
Intervention: General population (non-ED group)
Number of subjects: 159
Study: 32167784

Group type: EXPERIMENTAL
Intervention: Direct Service Model (6 sessions over 22 weeks of pharmacotherapy followed by behavior training)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Direct Service Model
Number of subjects: 223

Group type: COMPARATOR
Intervention: Consultation Model (single-session consultation)
Number of subjects: 223
Study: 36115963

Group type: EXPERIMENTAL
Intervention: TransformUs intervention
Number of subjects: 407
Study: 34112322

Group type: EXPERIMENTAL
Intervention: Strategies to end gender inequality in cardiovascular clinical trial leadership
Number of subjects: 10
Study: 35503446

Group type: EXPERIMENTAL
Intervention: Capsaicin (1.5 μg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 33882541

Group type: EXPERIMENTAL
Intervention: High Dose TXA (30 mg/kg loading dose followed by 10 mg/kg/h infusion)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Low Dose TXA (10 mg/kg loading dose followed by 1 mg/kg/h infusion)
Number of subjects: 166

Group type: COMPARATOR
Intervention: High Dose TXA
Number of subjects: 166

Group type: COMPARATOR
Intervention: Low Dose TXA
Number of subjects: 166
Study: 35131133

Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA COVID-19 vaccine
Number of subjects: 3813

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3813
Study: 34808620

Group type: EXPERIMENTAL
Intervention: Remifentanil with lidocaine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sufentanil with lidocaine
Number of subjects: 66
Study: 32607749

Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 (0.125, 0.250, or 0.500 million international units (MIU)/m2, given daily for 5 days and then fortnightly for 1 year)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 (0.250 and 0.500 MIU m−2 day−1)
Number of subjects: 24
Study: 35543439

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Plain balloon angioplasty
Number of subjects: 256
Study: 33232472

Group type: EXPERIMENTAL
Intervention: Autologous transplantation planned group
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Non-transplant planned group
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Patients with improved renal function
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Current therapies
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Patients with high free light chain at baseline
Number of subjects: 2334
Study: 36350332

Group type: EXPERIMENTAL
Intervention: Gamified mobile application for somatosensory training (daily use for 4 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control phase (no use of the new system for 4 weeks)
Number of subjects: 35
Study: 33907260

Group type: EXPERIMENTAL
Intervention: Post-stroke physical activity after 6 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Pre-stroke physical activity
Number of subjects: 49
Study: 33559636

Group type: EXPERIMENTAL
Intervention: Incisional Negative Pressure Wound Therapy (INPWT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional dressing
Number of subjects: 65
Study: 36517290

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 34255680

Group type: EXPERIMENTAL
Intervention: Home Exercise Program (HEP) delivered via telerehabilitation, 12 weeks duration, performed 2.04 times per week (95% CI 1.25‐4.08).
Number of subjects: 11
Study: 33414824

Group type: EXPERIMENTAL
Intervention: BCI group (motor imagery-based brain-computer interface with functional electrical stimulation)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (traditional rehabilitation therapy)
Number of subjects: 16
Study: 35341629

Group type: EXPERIMENTAL
Intervention: Suture anchor repair
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transosseous sutures
Number of subjects: 60
Study: 32811160

Group type: EXPERIMENTAL
Intervention: ImPACT intervention strategies
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 35222903

Group type: EXPERIMENTAL
Intervention: Nicotinamide 1000 mg once daily for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (antidiabetic therapy only)
Number of subjects: 70
Study: 35594970

Group type: EXPERIMENTAL
Intervention: Online cognitive behavior therapy (CBT) program with 8 modules and 8, 30-minute telephone sessions with a therapist (n = 45)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Wait control group (n = 46)
Number of subjects: 91
Study: 33131927

Group type: EXPERIMENTAL
Intervention: Enriched report informed by best practices
Number of subjects: 470

Group type: COMPARATOR
Intervention: Standard CPMC report
Number of subjects: 470
Study: 33032546

Group type: EXPERIMENTAL
Intervention: Intervention group (N = 55)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (N = 54)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 184
Study: 36171040

Group type: EXPERIMENTAL
Intervention: Integrated GP-paediatrician model of care (weekly co-consultation sessions, monthly case discussions, phone and email support)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Integrated GP-paediatrician model of care
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Implementation evaluation of the model
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Health economic evaluation
Number of subjects: 22
Study: 33533682

Group type: EXPERIMENTAL
Intervention: Virtual Reality Training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional Exercise Program
Number of subjects: 32
Study: 32085929

Group type: EXPERIMENTAL
Intervention: Microdebrider assisted turbinoplasty (MAT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Coblation assisted turbinoplasty (CAT)
Number of subjects: 33
Study: 35073986

Group type: EXPERIMENTAL
Intervention: Resistant potato starch (RPS), 15 g per day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cornstarch (digestible starch control), 15 g per day
Number of subjects: 36
Study: 33441315

Group type: EXPERIMENTAL
Intervention: Non-operative treatment pathway (broad-spectrum antibiotics and active observation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Appendicectomy
Number of subjects: 50
Study: 34033271

Group type: EXPERIMENTAL
Intervention: Terminal insomnia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial/middle insomnia
Number of subjects: 0
Study: 32304983

Group type: EXPERIMENTAL
Intervention: Female MS patients
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Male MS patients
Number of subjects: 200

Group type: COMPARATOR
Intervention: Healthy females
Number of subjects: 200

Group type: COMPARATOR
Intervention: Healthy males
Number of subjects: 200
Study: 36395635

Group type: EXPERIMENTAL
Intervention: Yoga intervention group (YG) received a 60-min structured yoga module online for 3 months in addition to standard medical care.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Yoga intervention group (YG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (CG) received only standard care during the same period.
Number of subjects: 120
Study: 33782657

Group type: EXPERIMENTAL
Intervention: HIV-positive children
Number of subjects: 482

Group type: COMPARATOR
Intervention: HIV-negative children
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: HIV-positive status
Number of subjects: 482
Study: 34863332

Group type: EXPERIMENTAL
Intervention: Lenzilumab (600 mg per dose, three doses delivered 8 hours apart)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Lenzilumab
Number of subjects: 520
Study: 32712342

Group type: EXPERIMENTAL
Intervention: Real anodal tDCS
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 28
Study: 36194764

Group type: EXPERIMENTAL
Intervention: NG/CT treatment records (n = 30,365)
Number of subjects: 190589

Group type: EXPERIMENTAL
Intervention: Treatment records associated with gonorrhea and/or chlamydia (n = 67,895)
Number of subjects: 190589

Group type: COMPARATOR
Intervention: Testing episodes not associated with treatment records (n = 122,694)
Number of subjects: 190589

Group type: EXPERIMENTAL
Intervention: Same-day treatment for NG/CT testing episodes
Number of subjects: 190589
Study: 33693791

Group type: EXPERIMENTAL
Intervention: Higher vegetable intake (per heaped tablespoon increase)
Number of subjects: 432732

Group type: EXPERIMENTAL
Intervention: Polygenic score for vegetable intake (per ordinal category increase)
Number of subjects: 432732

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted vegetable intake (2-sample MR)
Number of subjects: 432732
Study: 32780636

Group type: EXPERIMENTAL
Intervention: Dextrose prolotherapy (DPT) (20% dextrose/0.2% lidocaine)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Lidocaine injection (0.2% lidocaine in sterile water)
Number of subjects: 29
Study: 36181074

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF) switching group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Entecavir (ETV) continuing group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall analysis of HBsAg decline
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF) switching group with baseline eGFR < 60
Number of subjects: 30

Group type: COMPARATOR
Intervention: Entecavir (ETV) continuing group with baseline eGFR < 60
Number of subjects: 30
Study: 33780506

Group type: EXPERIMENTAL
Intervention: Simple information treatment (explained that added sugars information was now available on the NF label)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Full information treatment (included additional details on interpreting added sugars content and associated diseases)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Accessing added sugars information
Number of subjects: 490
Study: 35558969

Group type: EXPERIMENTAL
Intervention: ApOx (apneic oxygenation) via low-flow nasal cannula (1 LPM for 0–1 month, 2 LPM for 1–12 months, 4 LPM for 1–7 years)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Classical rapid sequence induction (no oxygen supplementation)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ApOx (apneic oxygenation)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Classical rapid sequence induction
Number of subjects: 64
Study: 34506548

Group type: EXPERIMENTAL
Intervention: AIR-BT
Number of subjects: 36

Group type: COMPARATOR
Intervention: Treadmill Test
Number of subjects: 36
Study: 35090674

Group type: EXPERIMENTAL
Intervention: Telemedical monitoring with implantable cardiac monitors
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 400
Study: 34043051

Group type: EXPERIMENTAL
Intervention: Foot massage during chemotherapy (4 sessions, 7 min each foot, 40 min intervals)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 88
Study: 32954737

Group type: EXPERIMENTAL
Intervention: Initial surgery followed by adjuvant chemotherapy
Number of subjects: 632

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy followed by cytoreductive surgery
Number of subjects: 632
Study: 34345908

Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Slow Maxillary Expansion (SME)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both RME and SME
Number of subjects: 26
Study: 33271505

Group type: EXPERIMENTAL
Intervention: C+UST (Cognitive training + Unstable Strength Training)
Number of subjects: 50

Group type: COMPARATOR
Intervention: UST (Unstable Strength Training)
Number of subjects: 50
Study: 32486838

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 575
Study: 36253166

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride plus potassium iodide (SDF + KI)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Resin-modified glass ionomer cement (RMGIC)
Number of subjects: 108
Study: 33306556

Group type: EXPERIMENTAL
Intervention: Enhanced-prophylaxis (fluconazole 100 mg/day, azithromycin, isoniazid, cotrimoxazole)
Number of subjects: 1781

Group type: COMPARATOR
Intervention: Standard-prophylaxis (cotrimoxazole)
Number of subjects: 1781
Study: 32612266

Group type: EXPERIMENTAL
Intervention: 3mensio (3m) software
Number of subjects: 100

Group type: COMPARATOR
Intervention: HeartNavigator3 (HN) software
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prosthesis choice simulation based on HN-measurements
Number of subjects: 100
Study: 36301896

Group type: EXPERIMENTAL
Intervention: Recognition of intrinsic values of sentient beings
Number of subjects: 1508

Group type: EXPERIMENTAL
Intervention: Concern for animal welfare
Number of subjects: 1508
Study: 34289879

Group type: EXPERIMENTAL
Intervention: Community-based health educational intervention administered by Female Community Health Volunteers (FCHVs)
Number of subjects: 1143
Study: 32346711

Group type: EXPERIMENTAL
Intervention: Topical doxycycline for 5 min before replantation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 38
Study: 36361001

Group type: EXPERIMENTAL
Intervention: Task-oriented activities of daily living (T-ADL) training
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional occupational therapy (OT)
Number of subjects: 33
Study: 35644154

Group type: EXPERIMENTAL
Intervention: Risankizumab 600 mg
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: Risankizumab 1200 mg
Number of subjects: 1549

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1549